ProCE Banner Activity

Treatment for EGFR-Mutant Lung Cancer After Progression on EGFR TKI

Slideset Download
Download this brief slideset on treatment options for patients with advanced EGFR-mutated NSCLC whose disease has progressed on first-line EGFR TKI therapy.

Released: November 19, 2021

Expiration: November 18, 2022

No longer available for credit.

Share

Faculty

Helena Yu

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York